These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 28193604)

  • 21. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Bonow RO; Nishimura RA; Thompson PD; Udelson JE
    J Am Coll Cardiol; 2015 Dec; 66(21):2385-2392. PubMed ID: 26542667
    [No Abstract]   [Full Text] [Related]  

  • 22. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance.
    Russo AM; Stainback RF; Bailey SR; Epstein AE; Heidenreich PA; Jessup M; Kapa S; Kremers MS; Lindsay BD; Stevenson LW
    Heart Rhythm; 2013 Apr; 10(4):e11-58. PubMed ID: 23473952
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of worksite health screening: a policy statement from the American Heart Association.
    Arena R; Arnett DK; Terry PE; Li S; Isaac F; Mosca L; Braun L; Roach WH; Pate RR; Sanchez E; Carnethon M; Whitsel LP
    Circulation; 2014 Aug; 130(8):719-34. PubMed ID: 25013030
    [No Abstract]   [Full Text] [Related]  

  • 24. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 1: Classification of Sports: Dynamic, Static, and Impact: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Levine BD; Baggish AL; Kovacs RJ; Link MS; Maron MS; Mitchell JH;
    Circulation; 2015 Dec; 132(22):e262-6. PubMed ID: 26621643
    [No Abstract]   [Full Text] [Related]  

  • 25. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension: A Scientific Statement from the American Heart Association and the American College of Cardiology.
    Black HR; Sica D; Ferdinand K; White WB;
    Circulation; 2015 Dec; 132(22):e298-302. PubMed ID: 26621647
    [No Abstract]   [Full Text] [Related]  

  • 26. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 14: Sickle Cell Trait: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Maron BJ; Harris KM; Thompson PD; Eichner ER; Steinberg MH;
    Circulation; 2015 Dec; 132(22):e343-5. PubMed ID: 26527715
    [No Abstract]   [Full Text] [Related]  

  • 27. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 15: Legal Aspects of Medical Eligibility and Disqualification Recommendations: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Mitten MJ; Zipes DP; Maron BJ; Bryant WJ;
    Circulation; 2015 Dec; 132(22):e346-9. PubMed ID: 26621654
    [No Abstract]   [Full Text] [Related]  

  • 28. Recommendations for the Implementation of Telehealth in Cardiovascular and Stroke Care: A Policy Statement From the American Heart Association.
    Schwamm LH; Chumbler N; Brown E; Fonarow GC; Berube D; Nystrom K; Suter R; Zavala M; Polsky D; Radhakrishnan K; Lacktman N; Horton K; Malcarney MB; Halamka J; Tiner AC;
    Circulation; 2017 Feb; 135(7):e24-e44. PubMed ID: 27998940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 8: Coronary Artery Disease: A Scientific Statement from the American Heart Association and American College of Cardiology.
    Thompson PD; Myerburg RJ; Levine BD; Udelson JE; Kovacs RJ;
    Circulation; 2015 Dec; 132(22):e310-4. PubMed ID: 26621649
    [No Abstract]   [Full Text] [Related]  

  • 30. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Estes NA; Kovacs RJ; Baggish AL; Myerburg RJ;
    Circulation; 2015 Dec; 132(22):e330-3. PubMed ID: 26621651
    [No Abstract]   [Full Text] [Related]  

  • 31. Integrating Inpatient Electronic Consultations in Cardiology Fellowship.
    Raber I; McCarthy CP; Wasfy JH
    J Am Coll Cardiol; 2019 Aug; 74(8):1151-1155. PubMed ID: 31439221
    [No Abstract]   [Full Text] [Related]  

  • 32. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Link MS; Estes NA; Maron BJ;
    Circulation; 2015 Dec; 132(22):e339-42. PubMed ID: 26621653
    [No Abstract]   [Full Text] [Related]  

  • 33. The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
    Jacobs AK; Anderson JL; Halperin JL
    J Am Coll Cardiol; 2014 Sep; 64(13):1373-84. PubMed ID: 25103073
    [No Abstract]   [Full Text] [Related]  

  • 34. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
    Goff DC; Lloyd-Jones DM; Bennett G; Coady S; D'Agostino RB; Gibbons R; Greenland P; Lackland DT; Levy D; O'Donnell CJ; Robinson JG; Schwartz JS; Shero ST; Smith SC; Sorlie P; Stone NJ; Wilson PW; Jordan HS; Nevo L; Wnek J; Anderson JL; Halperin JL; Albert NM; Bozkurt B; Brindis RG; Curtis LH; DeMets D; Hochman JS; Kovacs RJ; Ohman EM; Pressler SJ; Sellke FW; Shen WK; Smith SC; Tomaselli GF;
    Circulation; 2014 Jun; 129(25 Suppl 2):S49-73. PubMed ID: 24222018
    [No Abstract]   [Full Text] [Related]  

  • 35. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Van Hare GF; Ackerman MJ; Evangelista JK; Kovacs RJ; Myerburg RJ; Shafer KM; Warnes CA; Washington RL
    J Am Coll Cardiol; 2015 Dec; 66(21):2372-2384. PubMed ID: 26542660
    [No Abstract]   [Full Text] [Related]  

  • 36. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Braverman AC; Harris KM; Kovacs RJ; Maron BJ;
    Circulation; 2015 Dec; 132(22):e303-9. PubMed ID: 26621648
    [No Abstract]   [Full Text] [Related]  

  • 37. The American Heart Association's recent scientific statement on cardiac critical care: implications for pediatric practice.
    Penny DJ; Shekerdemian LS
    Congenit Heart Dis; 2013; 8(1):3-19. PubMed ID: 23280102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2015 SPCTPD/ACC/AAP/AHA Training Guidelines for Pediatric Cardiology Fellowship Programs (Revision of the 2005 Training Guidelines for Pediatric Cardiology Fellowship Programs): Introduction.
    Ross RD; Brook M; Koenig P; Feinstein JA; Lang P; Spicer RL; Vincent JA
    J Am Coll Cardiol; 2015 Aug; 66(6):672-6. PubMed ID: 25777634
    [No Abstract]   [Full Text] [Related]  

  • 39. Knowledge Gaps in Cardiovascular Care of Older Adults: A Scientific Statement from the American Heart Association, American College of Cardiology, and American Geriatrics Society: Executive Summary.
    Rich MW; Chyun DA; Skolnick AH; Alexander KP; Forman DE; Kitzman DW; Maurer MS; McClurken JB; Resnick BM; Shen WK; Tirschwell DL
    J Am Geriatr Soc; 2016 Nov; 64(11):2185-2192. PubMed ID: 27673575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Maron BJ; Zipes DP; Kovacs RJ
    J Am Coll Cardiol; 2015 Dec; 66(21):2343-2349. PubMed ID: 26542655
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.